Stepping Stones and Creating Futures Plus Pilot

May 7, 2024 updated by: Andrew Gibbs, University of Exeter

An Inter-disciplinary Approach to Understanding and Intervening on Contextual Factors That Shape HIV-risk for Young Women and Men in South Africa: Phase 2 - the Feasibility, Acceptability and Potential Effect Size of a Pilot Randomised Controlled Trial

The goal of this randomised controlled clinical trial is to test the Stepping Stones and Creating Futures Plus (SSCF+) intervention, in young (18-25 years) people living in urban informal settlements in Durban and rural communities in KwaZulu-Natal, South Africa. The main questions it aims to answer are:

  • Is the intervention acceptable and feasible
  • What is the potential effect size on key outcomes of intimate partner violence

Participants will be randomised (1:1) to compare SSCF+ and a control arm to see if there are differences between the two on intimate partner violence.

Study Overview

Detailed Description

Intimate partner violence is very common in South Africa, particularly urban informal settlements. We have co-developed an intervention, called Stepping Stones and Creating Futures Plus (SSCF+), which will be evaluated in women and men aged 18-25 years living in KwaZulu-Natal, South Africa.

This is a pilot randomised controlled trial and as such there is focus on understanding whether the intervention is acceptable (to participants), feasible to deliver, and the potential effect sizes we may see in a full trial.

Study Type

Interventional

Enrollment (Actual)

323

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Durban, South Africa
        • South African Medical Research Council

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 25 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Normally resident in the community where recruiting
  • Aged 18-30 years old
  • Not in formal employment, or full-time education
  • Able to communicate in the main languages of the study (English, isiXhosa or isiZulu)
  • Able to provide informed consent

Exclusion Criteria:

  • Only in the community temporarily
  • Unable to provide informed consent
  • Under 18 years of age, or over 31 years old at point of recruitment
  • Unable to communicate in main study languages

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SSCF+
Stepping Stones and Creating Futures Plus (SSCF+). Small group intervention, comprising approximately 15 sessions (each session ~3 hours), addressing gender, livelihoods, mental health.
Group-based intervention delivered to small friendship networks, by a facilitator.
No Intervention: Control
No intervention control (wait-list)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical Intimate Partner Violence
Time Frame: 6 months
Past 6 month experience (women) and perpetration (men) of physical IPV as assessed using WHO measure of IPV (5 items, binary)
6 months
Sexual Intimate Partner Violence
Time Frame: 6 months
Past 6 month experience (women) and perpetration (men) of sexual IPV as assessed using WHO measure of IPV (3 items)
6 months
Severe Intimate partner violence
Time Frame: 6 months
Past 6 month experience (women) and perpetration (men) of severe IPV as assessed using WHO IPV scale (8 items, coded into a binary)
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depressive symptoms
Time Frame: 6 months
Mean score of depressive symptoms as assessed by the Center for Epidemiology Studies Depression Scale (CESD) comprising 20 items
6 months
Post-traumatic-stress symptoms
Time Frame: 6 months
Post traumatic stress symptoms experienced in past week (mean) as assessed through the Harvard Trauma Questionnaire (16 items)
6 months
Emotional Dysregulation
Time Frame: 6 months
Assessed via the Difficulties in Emotional Regulation Scale (DERS) short form, 16 items. Mean score.
6 months
Earnings
Time Frame: 6 months
Self-reported past month earnings (South African Rand)
6 months
Savings
Time Frame: 6 months
Self-report past month savings (South African Rand)
6 months
Hunger
Time Frame: 6 months
Past month food insecurity assessed through the 3 items of the Household Food Insecurity Access Scale (HFIAS)
6 months
Livelihood Activities
Time Frame: 6 months
Frequency of livelihood strengthening activities in the past 3 months, assessed through seven items
6 months
Work stress
Time Frame: 6 months
Experience of stress because of lack of work and money assessed through 4 items
6 months
Work shame
Time Frame: 6 months
Experience of shame because of lack of work and money assessed through 4 items
6 months
Capabilities
Time Frame: 6 months
Experience of capabilities assessed through 5 items of a modified ICECAP scale
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rachel Jewkes, Medical Research Council, South Africa
  • Principal Investigator: Andrew Gibbs, University of Exeter
  • Principal Investigator: Jenevieve Mannell, University College, London

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 24, 2023

Primary Completion (Actual)

November 28, 2023

Study Completion (Actual)

November 28, 2023

Study Registration Dates

First Submitted

March 13, 2023

First Submitted That Met QC Criteria

March 13, 2023

First Posted (Actual)

March 24, 2023

Study Record Updates

Last Update Posted (Actual)

May 8, 2024

Last Update Submitted That Met QC Criteria

May 7, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • EC023-10/2022

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymised data will be shared within 12 months of study completion on University of Exeter and South African Medical Research Council data repository.

IPD Sharing Time Frame

12 months from completion of study

IPD Sharing Access Criteria

Freely available

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intimate Partner Violence

Clinical Trials on Stepping Stones and Creating Futures Plus (SSCF+)

Subscribe